StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Prabhudas Lilladher

BUYRainbow Childrens Medicare Limited
Rainbow Childrens Medicare share price target & all analyst calls

byPrabhudas LilladherHorizon: NA (inferred 1 year)3 Nov 2026via Moneycontrol Broker Research

Entry₹1,246.4Inferred
Target₹1,650
Total upside +32.38%
Stop lossNot given
CMP₹1,244.41d ago
Active-0.16%+32.59%upside left 12 mo left
Follow Prabhudas Lilladher for new calls(71% target hit, 418 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alertsSee 8 other Long-term calls on RAINBOWSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:28 pm IST
11 supporting2 neutral1 opposing
Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

7 other SEBI-registered advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · same horizon·3 Nov · 4d ago

Rainbow Children’s Medicare Q2: Revenue rises 23%, profit grows 11%

NewsCnbc-Tv18·31 Oct · 6d ago

(opens in new tab)

Rainbow Children's Medicare reported Q2 FY27 revenue growth of 23% year-on-year, with EBITDA and PAT growing by 14% and 11% respectively, driven by healthy patient volumes and network expansion.

BSE · Company Update·31 Oct · 6d ago

(opens in new tab)

Rainbow Children's Medicare reported Q2 FY27 revenue of INR 5,480 million, up 23% YoY, and PAT of INR 839 million, up 11% YoY, driven by operational growth and expansion.

BSE · Company Update·31 Oct · 6d ago

(opens in new tab)
Neutral / worth noting (2)

Unaudited Standalone & Consolidated Financial Results for Quarter and Half year ended September 30, 2026

BSE · Board Meeting·31 Oct · 6d ago

(opens in new tab)
Weighs against the BUY call (1)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rainbow Childrens Medicare

All analyst calls on Rainbow Childrens Medicare

More from Prabhudas Lilladher

Every call and its outcome